Aster DM Healthcare reported EBITDA margin of 21.4% in Q2FY25 vs. 6.8% in Q2FY24. Margin expansion is expected to continue over the next 2-3 years. The company plans to add ~1,800 beds by FY27.
What is covered in the Full Insight:
Introduction to Aster DM Healthcare
Expansion and Future Plans
Financial and Operational Performance
Industry Outlook and Strategic Positioning
Potential Risks and Peer Comparison
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.